MLVBX
Price
$18.94
Change
-$0.10 (-0.53%)
Updated
Dec 17 closing price
VFINX
Price
$559.88
Change
-$2.16 (-0.38%)
Updated
Dec 17 closing price
Ad is loading...

MLVBX vs VFINX

Header iconMLVBX vs VFINX Comparison
Open Charts MLVBX vs VFINXBanner chart's image
MFS Low Volatility Equity B
Price$18.94
Change-$0.10 (-0.53%)
VolumeN/A
CapitalizationN/A
Vanguard 500 Index Investor
Price$559.88
Change-$2.16 (-0.38%)
VolumeN/A
CapitalizationN/A
MLVBX vs VFINX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MLVBX vs. VFINX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLVBX is a Hold and VFINX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VFINX has more cash in the bank: 1.37T vs. MLVBX (405M). VFINX pays higher dividends than MLVBX: VFINX (1.24) vs MLVBX (0.12). MLVBX was incepted earlier than VFINX: MLVBX (11 years) vs VFINX (48 years). MLVBX is a more actively managed with annual turnover of: 39.00 vs. VFINX (2.00). VFINX has a lower initial minimum investment than MLVBX: VFINX (0) vs MLVBX (1000). VFINX annual gain was more profitable for investors over the last year : 27.63 vs. MLVBX (3.98). VFINX return over 5 years is better than : 88.65 vs. MLVBX (13.57).
MLVBXVFINXMLVBX / VFINX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years48 years-
Gain YTD3.02027.27511%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets405M1.37T0%
Annual Yield % from dividends0.121.249%
Returns for 1 year3.9827.6314%
Returns for 3 years-11.2630.99-36%
Returns for 5 years13.5788.6515%
Returns for 10 years69.26193.6236%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LX6.090.31
+5.36%
LexinFintech Holdings Ltd
DDOG156.911.09
+0.70%
Datadog
PAR78.060.08
+0.10%
PAR Technology Corp
HRI195.00-4.00
-2.01%
Herc Holdings
BRNS0.92-0.05
-5.26%
Barinthus Biotherapeutics plc